United States Sets One-Day Record: Over 65,500 New Confirmed Cases of Covid
The United States on Thursday (7/10) reported across states, according to a Reuter’s tally, more than 60,500 new cases of Covid, setting the new record for the number of those confirmed to be infected in one day. As the cases are steadily on the rise in 41 out of the...
Covid Potential for Brain Damage, According to Scientists
A study conducted by researchers at University College London (UCL) reported 43 cases of patients diagnosed with Covid experiencing temporary brain damage. The scientists warned that new evidence suggests potential issues of severe neurological complications, like...
Over 200 Scientists Claim Covid Is Airborne According to NYT
239 scientists from 32 countries have submitted an open letter with mounting evidence to the WHO that the Covid can be spread through the air. The WHO has stated that only after medical procedures that produce aerosols, or droplets smaller than 5 microns is the virus...
Early Potential in Human Trials for Covid Vaccine
BioNTech, and Pfizer have partnered to produce one of the 17 Covid vaccines currently in development. The vaccine has shown promising early-stage human trials among 24 participants, alongside other pharmaceutical companies like Moderna, Inovio Pharmaceuticals,...
Gilead Sets Price for Covid Treatment Remdesivir
Gilead Sciences, the biotech company based out of California that created one of the first original treatments for Covid, has set the price for remdesivir between $2,340 and $3,120 for a typical course treatment. While remdesivir has still yet to prove to reduce...
Covid Infection Rates Could Be 10 Times Higher Than Reports Show
The Center for Disease Control (CDC) reported last night (6/24) that the actual number of patients in the United States infected with Covid could potentially be ten times higher. The estimate comes from a serology test that is used to determine if an individual has...
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com